Rebecca Kunder

893 total citations
11 papers, 674 citations indexed

About

Rebecca Kunder is a scholar working on Molecular Biology, Surgery and Radiology, Nuclear Medicine and Imaging. According to data from OpenAlex, Rebecca Kunder has authored 11 papers receiving a total of 674 indexed citations (citations by other indexed papers that have themselves been cited), including 6 papers in Molecular Biology, 3 papers in Surgery and 3 papers in Radiology, Nuclear Medicine and Imaging. Recurrent topics in Rebecca Kunder's work include Monoclonal and Polyclonal Antibodies Research (3 papers), Fibroblast Growth Factor Research (2 papers) and Genomics and Chromatin Dynamics (2 papers). Rebecca Kunder is often cited by papers focused on Monoclonal and Polyclonal Antibodies Research (3 papers), Fibroblast Growth Factor Research (2 papers) and Genomics and Chromatin Dynamics (2 papers). Rebecca Kunder collaborates with scholars based in United States, United Kingdom and New Zealand. Rebecca Kunder's co-authors include Ching‐yi Chang, Donald P. McDonnell, Dmitri Kazmin, James D. Joseph, Jeff S. Jasper, Bryan M. Wittmann, Huaxia Cui, John D. Norris, Daju Fan and William J. Zuercher and has published in prestigious journals such as The Lancet, SHILAP Revista de lepidopterología and Molecular Cell.

In The Last Decade

Rebecca Kunder

11 papers receiving 667 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Rebecca Kunder United States 8 342 154 151 141 131 11 674
Saradhi Mallampati United States 14 275 0.8× 94 0.6× 110 0.7× 155 1.1× 42 0.3× 34 592
М. В. Немцова Russia 15 556 1.6× 105 0.7× 104 0.7× 183 1.3× 109 0.8× 93 885
Lilian Varricchio United States 19 493 1.4× 184 1.2× 322 2.1× 211 1.5× 63 0.5× 37 1.1k
Elena Tirrò Italy 19 423 1.2× 123 0.8× 67 0.4× 261 1.9× 81 0.6× 48 1.0k
Maria Stella Pennisi Italy 14 294 0.9× 77 0.5× 58 0.4× 187 1.3× 100 0.8× 34 798
R.J. Vlietstra Netherlands 8 398 1.2× 434 2.8× 215 1.4× 142 1.0× 52 0.4× 10 911
Jennelle C. Hodge United States 19 411 1.2× 398 2.6× 161 1.1× 119 0.8× 49 0.4× 39 957
Florence Namour Belgium 14 188 0.5× 57 0.4× 108 0.7× 194 1.4× 167 1.3× 29 646
Irma M. Sáinz United States 16 236 0.7× 125 0.8× 29 0.2× 117 0.8× 52 0.4× 25 741
Carla B. Ripamonti Italy 14 452 1.3× 38 0.2× 127 0.8× 89 0.6× 73 0.6× 29 907

Countries citing papers authored by Rebecca Kunder

Since Specialization
Citations

This map shows the geographic impact of Rebecca Kunder's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Rebecca Kunder with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Rebecca Kunder more than expected).

Fields of papers citing papers by Rebecca Kunder

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Rebecca Kunder. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Rebecca Kunder. The network helps show where Rebecca Kunder may publish in the future.

Co-authorship network of co-authors of Rebecca Kunder

This figure shows the co-authorship network connecting the top 25 collaborators of Rebecca Kunder. A scholar is included among the top collaborators of Rebecca Kunder based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Rebecca Kunder. Rebecca Kunder is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

11 of 11 papers shown
1.
Robinson, William H., David Fiorentino, Leland W.K. Chung, et al.. (2024). Cutting-edge approaches to B-cell depletion in autoimmune diseases. Frontiers in Immunology. 15. 1454747–1454747. 13 indexed citations
2.
Yoshida, Kenta, et al.. (2024). Simulation‐based evaluation of personalized dosing approaches for anti‐FGFR/KLB bispecific antibody fazpilodemab. CPT Pharmacometrics & Systems Pharmacology. 13(4). 544–550. 4 indexed citations
3.
Jamalian, Samira, Xin Sheng, Xiaoying Yang, et al.. (2024). A Phase 1a Study to Evaluate Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of RO7303509, an Anti-TGFβ3 Antibody, in Healthy Volunteers. Rheumatology and Therapy. 11(3). 755–771. 4 indexed citations
4.
Tang, Fei, Rebecca Kunder, Tom Chu, et al.. (2023). First‐in‐human phase 1 trial evaluating safety, pharmacokinetics, and pharmacodynamics of NLRP3 inflammasome inhibitor, GDC‐2394, in healthy volunteers. Clinical and Translational Science. 16(9). 1653–1666. 37 indexed citations
5.
Dash, Ajit, Jill Fredrickson, Nicholas Lewin‐Koh, et al.. (2022). Fibroblast growth factor receptor 1/Klothoβ agonist BFKB8488A improves lipids and liver health markers in patients with diabetes or NAFLD: A phase 1b randomized trial. Hepatology. 78(3). 847–862. 24 indexed citations
6.
Kivitz, Alan, F. Matzkies, Afsaneh Mozaffarian, et al.. (2019). FRI0150 GS-9876, A NOVEL, HIGHLY SELECTIVE, SYK INHIBITOR IN PATIENTS WITH ACTIVE RHEUMATOID ARTHRITIS: SAFETY, TOLERABILITY AND EFFICACY RESULTS OF A PHASE 2 STUDY. Annals of the Rheumatic Diseases. 78. 746–747. 2 indexed citations
7.
Mease, Philip J., Laura C. Coates, Philip Helliwell, et al.. (2018). Efficacy and safety of filgotinib, a selective Janus kinase 1 inhibitor, in patients with active psoriatic arthritis (EQUATOR): results from a randomised, placebo-controlled, phase 2 trial. The Lancet. 392(10162). 2367–2377. 156 indexed citations
8.
Kunder, Rebecca, Christian A. Kunder, Heather Y. Sun, et al.. (2013). Pediatric Plastic Bronchitis: Case Report and Retrospective Comparative Analysis of Epidemiology and Pathology. SHILAP Revista de lepidopterología. 2013. 1–8. 31 indexed citations
9.
Chang, Ching‐yi, Dmitri Kazmin, Jeff S. Jasper, et al.. (2011). The Metabolic Regulator ERRα, a Downstream Target of HER2/IGF-1R, as a Therapeutic Target in Breast Cancer. Cancer Cell. 20(4). 500–510. 120 indexed citations
10.
Dwyer, Mary A., James D. Joseph, Matthew L. Eaton, et al.. (2010). WNT11 Expression Is Induced by Estrogen-Related Receptor α and β-Catenin and Acts in an Autocrine Manner to Increase Cancer Cell Migration. Cancer Research. 70(22). 9298–9308. 121 indexed citations
11.
Norris, John D., Ching‐yi Chang, Bryan M. Wittmann, et al.. (2009). The Homeodomain Protein HOXB13 Regulates the Cellular Response to Androgens. Molecular Cell. 36(3). 405–416. 162 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Saradhi Mallampati Breakdown of academic impact, for papers by М. В. Немцова Breakdown of academic impact, for papers by Lilian Varricchio Breakdown of academic impact, for papers by Elena Tirrò Breakdown of academic impact, for papers by Maria Stella Pennisi Breakdown of academic impact, for papers by R.J. Vlietstra Breakdown of academic impact, for papers by Jennelle C. Hodge Breakdown of academic impact, for papers by Florence Namour Breakdown of academic impact, for papers by Irma M. Sáinz Breakdown of academic impact, for papers by Carla B. Ripamonti
Rankless by CCL
2026